Key Takeaways Anti aging stem cell treatment uses adult stem cells to support the body’s own healing process, not to reverse aging on its own. Good candidates are generally adults in stable overall health who want to support the body’s natural repair process before major decline sets in. Most specialists
Key Takeaways A 2026 study in Scientific Reports followed 49 patients with steroid-resistant GvHD treated with Wharton’s jelly MSCs at four hospitals in Spain. At day 28, 71.4% of patients responded to treatment. One-year survival reached 55.1%. Batches that scored above 70% on a potency test produced far better outcomes,
Key Takeaways Stem cell treatment for congestive heart failure targets the weak heart muscle directly, rather than just managing symptoms. Mesenchymal stem cells MSCs release growth factors that support cardiac repair, reduce inflammation, and may promote the growth of new blood vessels in the heart. Clinical trials and clinical studies
Key Takeaways Stem cell treatment for ulcerative colitis targets the immune dysfunction at the root of the disease, not just the symptoms in the colon and rectum. Mesenchymal stem cells MSCs reduce harmful immune responses, expand regulatory T cells, and release growth factors that support mucosal healing and tissue regeneration.
Key Takeaways Researchers at MUSC report that engineered mesenchymal stem cells reversed new-onset type 1 diabetes in mice, pointing to the disease’s immune response rather than just its symptoms. The cells were modified to overexpress a protein called alpha-1 antitrypsin, which calmed the autoimmune attack and protected insulin producing beta
Key Takeaways Stem cell therapy can slow cellular aging by targeting the immune system dysfunction and chronic inflammation that drive the aging process at the cellular level. Growth factors released by mesenchymal stem cells (MSCs) support boosting collagen, repairing damaged tissue, and improving skin quality from within. Findings show improvements
Key Takeaways Umbilical cord derived mesenchymal stem cells (UC-MSCs) are a well-studied source of MSC therapy for ulcerative colitis UC, with strong anti-inflammatory and tissue repair properties. UC-MSCs home to inflamed tissue, calm overactive immune cells, and promote macrophage repolarisation from a damaging M1 state to a healing M2 state.
Key Takeaways The realistic goals of stem cell therapy for MS are slowing disease activity, reducing fatigue, and improving mobility, not reversing all past damage. Mesenchymal stem cells (MSCs) calm the immune system and protect nerve fibers. Hematopoietic stem cell transplant (HSCT) goes further, aiming to reset the immune system
Quick Summary Family support is essential for recovery after cell-based therapy for hypoxic brain damage. Families help with daily rehabilitation exercises, motor function practice, medication schedules, and emotional support. Recovery takes months or years, and consistent family involvement improves both short-term and long-term neurological outcomes alongside treatments like mesenchymal stem
Quick Summary New 2026 Phase 2 data for BRTX-100 (autologous mesenchymal stem cell therapy for chronic lumbar disc disease) shows sustained pain and functional improvements at 52 weeks: 56% of evaluable patients had ≥50% VAS pain reduction, 64% had ≥50% ODI disability improvement. Safety data reported no dose-limiting toxicities or
